BR122022016077A2 - - Google Patents

Info

Publication number
BR122022016077A2
BR122022016077A2 BR122022016077A BR122022016077A BR122022016077A2 BR 122022016077 A2 BR122022016077 A2 BR 122022016077A2 BR 122022016077 A BR122022016077 A BR 122022016077A BR 122022016077 A BR122022016077 A BR 122022016077A BR 122022016077 A2 BR122022016077 A2 BR 122022016077A2
Authority
BR
Brazil
Application number
BR122022016077A
Other languages
Portuguese (pt)
Other versions
BR122022016077B1 (pt
BR122022016077A8 (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR122022016077A2 publication Critical patent/BR122022016077A2/pt
Publication of BR122022016077A8 publication Critical patent/BR122022016077A8/pt
Publication of BR122022016077B1 publication Critical patent/BR122022016077B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Biophysics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR122022016077-8A 2013-12-24 2014-12-23 Uso de 5-colesten-3,25-diol, 3-sulfato (25hc3s) ou um sal farmaceuticamente aceitável do mesmo BR122022016077B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361920617P 2013-12-24 2013-12-24
US61/920,617 2013-12-24
PCT/US2014/072128 WO2015100312A1 (en) 2013-12-24 2014-12-23 Uses of oxygenated cholesterol sulfates (ocs)

Publications (3)

Publication Number Publication Date
BR122022016077A2 true BR122022016077A2 (enExample) 2017-08-08
BR122022016077A8 BR122022016077A8 (pt) 2023-05-09
BR122022016077B1 BR122022016077B1 (pt) 2023-08-29

Family

ID=

Also Published As

Publication number Publication date
AU2020202891A1 (en) 2020-05-21
KR102530119B1 (ko) 2023-05-08
KR20230065387A (ko) 2023-05-11
HRP20220978T1 (hr) 2022-11-11
EP3639828B1 (en) 2021-12-01
CY1125028T1 (el) 2023-06-09
SMT202200314T1 (it) 2022-09-14
US20230310458A1 (en) 2023-10-05
JP2024009887A (ja) 2024-01-23
SI3086793T1 (sl) 2022-10-28
IL282010B (en) 2022-07-01
KR102655918B1 (ko) 2024-04-09
EA201990684A1 (ru) 2020-12-30
LT3086793T (lt) 2022-08-25
EP3086793A1 (en) 2016-11-02
MX377151B (es) 2025-03-07
IL282010A (en) 2021-05-31
BR122022016077A8 (pt) 2023-05-09
BR112016014611A2 (pt) 2017-08-08
WO2015100312A1 (en) 2015-07-02
AU2022204450A1 (en) 2022-07-14
AU2014369916A1 (en) 2016-06-16
HUE059914T2 (hu) 2023-01-28
US20170014429A1 (en) 2017-01-19
DK3639828T3 (da) 2022-02-14
PT3086793T (pt) 2022-07-20
EA032777B1 (ru) 2019-07-31
US10272097B2 (en) 2019-04-30
KR20160102301A (ko) 2016-08-29
HUE057649T2 (hu) 2022-05-28
CN105899213B (zh) 2021-03-16
EP3639828A1 (en) 2020-04-22
EP3086793B1 (en) 2022-05-11
KR20240051283A (ko) 2024-04-19
US20210046091A1 (en) 2021-02-18
JP2017505761A (ja) 2017-02-23
CA2932300A1 (en) 2015-07-02
CY1125475T1 (el) 2025-05-09
US10786517B2 (en) 2020-09-29
PT3639828T (pt) 2022-02-04
TWI782421B (zh) 2022-11-01
SI3639828T1 (sl) 2022-04-29
SMT202200094T1 (it) 2022-05-12
CA3195252A1 (en) 2015-07-02
US20260199374A1 (en) 2026-07-16
ZA201603580B (en) 2017-09-27
JP7009059B2 (ja) 2022-02-10
AU2022204450B2 (en) 2024-08-29
HRP20220112T1 (hr) 2022-04-15
MX2019003547A (es) 2019-06-17
TWI816417B (zh) 2023-09-21
EP3086793A4 (en) 2018-01-10
IL294448A (en) 2022-09-01
IL246339B (en) 2021-04-29
CN113599388A (zh) 2021-11-05
PL3639828T3 (pl) 2022-05-02
AU2020202891B2 (en) 2022-03-24
TW202313060A (zh) 2023-04-01
DK3086793T3 (da) 2022-08-01
JP7289030B2 (ja) 2023-06-09
RS63002B1 (sr) 2022-03-31
US11612609B2 (en) 2023-03-28
MX389828B (es) 2025-03-20
JP2020186241A (ja) 2020-11-19
ES2922501T3 (es) 2022-09-15
LT3639828T (lt) 2022-03-25
US20190350945A1 (en) 2019-11-21
EP4082550A1 (en) 2022-11-02
TWI734665B (zh) 2021-08-01
BR112016014611A8 (pt) 2023-05-09
JP7364759B2 (ja) 2023-10-18
IL246339A0 (en) 2016-08-31
CA2932300C (en) 2023-07-18
EA201691305A1 (ru) 2016-10-31
EP3639828B8 (en) 2022-01-05
PL3086793T3 (pl) 2023-01-30
MX2021011641A (es) 2023-03-10
MX2023002679A (es) 2023-04-03
TW202348234A (zh) 2023-12-16
CN105899213A (zh) 2016-08-24
RS63474B1 (sr) 2022-08-31
JP2023002544A (ja) 2023-01-10
ES2906865T3 (es) 2022-04-20
TW202137988A (zh) 2021-10-16
MX2016008459A (es) 2016-10-14
TW201609110A (zh) 2016-03-16

Similar Documents

Publication Publication Date Title
AP2016009275A0 (enExample)
BR112015007533A2 (enExample)
BR102016010778A2 (enExample)
BR112014017733A2 (enExample)
BR112014017739A2 (enExample)
BR112014018502A2 (enExample)
BR112014019326A2 (enExample)
BR112014018516A2 (enExample)
BR112014017765A2 (enExample)
BR112014018480A2 (enExample)
BR112014017855A2 (enExample)
BR112014020341A2 (enExample)
BR112014021878A2 (enExample)
BR112014018207A2 (enExample)
BR112014017901A2 (enExample)
BR112016000179A2 (enExample)
BR112014018483A2 (enExample)
BR112014017722A2 (enExample)
BR112014017794A2 (enExample)
BR112014018578A2 (enExample)
BR112014017601A2 (enExample)
BR112015015312A2 (enExample)
BR112014024039A2 (enExample)
BR112014018496A2 (enExample)
BR112014019048A2 (enExample)

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: VIRGINIA COMMONWEALTH UNIVERSITY (US) ; DURECT CORPORATION (US) ; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2014, OBSERVADAS AS CONDICOES LEGAIS